stockrowBioMarin Pharmaceutical Inc.
BMRN Healthcare Biotechnology
BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- −296.6%
- Free cash flow
- −52.3%
- Total debt
- +599.5%
Quarter to September 2026, against a year earlier
Follow BMRN
Alert me
BioMarin Pharmaceutical Inc. (BMRN) Gross margin
BioMarin Pharmaceutical Inc.'s gross margin over the twelve months to 30 September 2026 was 76.0%, down 1.8 percentage points from fiscal 2025 (77.7%). Over the past ten years it has ranged from 71.8% (fiscal 2020) to 82.9% (fiscal 2015); the current reading is higher than 36% of that period. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 77.7% | (1.94) |
| FY2024 | 79.7% | 1.66 |
| FY2023 | 78.0% | 2.01 |
| FY2022 | 76.0% | 1.48 |
| FY2021 | 74.5% | 2.70 |
| FY2020 | 71.8% | (7.09) |
| FY2019 | 78.9% | 0.05 |
| FY2018 | 78.9% | (2.73) |
| FY2017 | 81.6% | 0.36 |
| FY2016 | 81.2% | (1.69) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 80.0% | 0.44 |
| Jun 2026 | 79.5% | 4.96 |
| Mar 2026 | 74.6% | 6.08 |
| Dec 2025 | 68.5% | (13.48) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| SMMT Summit Therapeutics PLC compare | 100.0% |
| KYMR Kymera Therapeutics, Inc. compare | 100.0% |
| IBRX ImmunityBio, Inc. compare | 99.3% |
| TGTX TG Therapeutics, Inc. compare | 82.4% |
| BMRN BioMarin Pharmaceutical Inc. | 76.0% |
| TECH Bio-Techne Corp compare | 65.8% |
| TWST Twist Bioscience Corporation compare | 52.0% |
| PCVX Vaxcyte, Inc. compare | 0.00% |
| CAI Caris Life Sciences,�Inc. compare | 0.00% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BMRN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement